Arena CT.gov Administrator
Arena Pharmaceuticals
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Arena CT.gov Administrator as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 03:50 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT04655599 · Effect of Olorinab on Gastrointestinal Transit in Patients With Irritable Bowel SyndromeArena Pharmaceuticals · terminated · Irritable Bowel Syndrome · study director
- Ph2NCT04162769 · A Study to Assess the Safety and Efficacy of Etrasimod in Subjects With Moderate-to-Severe Atopic DermatitisArena Pharmaceuticals · completed · Atopic Dermatitis · study director
- Ph2NCT04043455 · Olorinab in Irritable Bowel Syndrome With Predominant Constipation (IBS-C) and Irritable Bowel Syndrome With Predominant Diarrhea (IBS-D)Arena Pharmaceuticals · terminated · Irritable Bowel Syndrome · study director
- Ph3NCT03996369 · Etrasimod Versus Placebo as Induction Therapy in Moderately to Severely Active Ulcerative ColitisArena Pharmaceuticals · completed · Ulcerative Colitis · study director
- Ph3NCT03945188 · Etrasimod Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative ColitisArena Pharmaceuticals · completed · Ulcerative Colitis · study director
- Ph2NCT03155945 · Tolerability, Pharmacokinetics, and Efficacy of APD371 in Participants With Crohn's Disease Experiencing Abdominal PainArena Pharmaceuticals · completed · Crohn's Disease, Abdominal Pain · study director
- Ph2NCT03155932 · Safety, Tolerability, and Efficacy of Etrasimod (APD334) in Participants With Primary Biliary CholangitisArena Pharmaceuticals · terminated · Primary Biliary Cholangitis · study director
- Ph2NCT03072953 · Efficacy and Safety of APD334 in Patients With Pyoderma GangrenosumArena Pharmaceuticals · terminated · Pyoderma Gangrenosum · study director
- Ph2NCT02536404 · Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative ColitisArena Pharmaceuticals · completed · Ulcerative Colitis · study director
- Ph2NCT02447302 · Safety and Efficacy of Etrasimod (APD334) in Patients With Ulcerative ColitisArena Pharmaceuticals · completed · Ulcerative Colitis · study director
- Ph2NCT00664664 · Subjective Study to Assess the Efficacy of APD125 in Patients With Sleep Maintenance InsomniaArena Pharmaceuticals · completed · Primary Insomnia · study director
Grants
NIH projects from RePORTER, fetched 2026-11-12 03:50 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.